Concepedia

Justine Tyler

JT

Statistics

Publications

7

Citations

1.3K

H-Index

7

Active since

2016

Affiliations

Institute of Cancer Research(Current)

Royal Marsden NHS Foundation Trust

Royal Marsden Hospital

Norfolk and Norwich University Hospital

Weston Park Cancer Centre

Justine Tyler is an author at Institute of Cancer Research specializing in radiation oncology, medicine, and dysphagia.

Publications per year

2016–2026

7

Publications

7

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 1K citations · Full text

, , +12

DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

Imran Petkar, Keith Rooney, Justin Roe et al. · BMC Cancer · 2016 · 111 citations · Full text

, , +17

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial

Christopher M. Nutting, Laura Finneran, Justin Roe et al. · The Lancet Oncology · 2023 · 105 citations · Full text

, , +17

Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.

Christopher M. Nutting, Keith Rooney, Bernadette Foran et al. · Journal of Clinical Oncology · 2020 · 33 citations

, , +17

An external dosimetry audit programme to credential static and rotational IMRT delivery for clinical trials quality assurance

David Eaton, Justine Tyler, Alex Backshall et al. · Physica Medica · 2017 · 24 citations

, , +14

1–5 of 7